Tuberculosis treatment must be evaluated for relative cost-effectiveness of inpatient and outpatient models of care as it will benefit regions where tuberculosis is endemic. It is highly recommended to treat the TB patient in ambulatory care instead of inpatient setting unless there are severe complications.
Tuberculosis cost-effectiveness of therapy
Multi-drug-resistant tuberculosis cost-effectiveness of therapy
Pneumonia cost-effectiveness of therapy
Leprosy cost-effectiveness of therapy
Bacterial pneumonia cost-effectiveness of therapy
Hospital-acquired pneumonia cost-effectiveness of therapy
Malaria cost-effectiveness of therapy
Pneumoconiosis cost-effectiveness of therapy